Rituximab vs Yttrium Y 90 Ibritumomab Tiuxetan

## Rituximab vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Yttrium Y 90 Ibritumomab Tiuxetan**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

## Chemical Properties

**Type**: Rituximab — Antibody; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.